Nevertheless, recent research has shed light on the presence of autoimmune antibodies in specific subsets of CIDP patients, targeting nodal-paranodal cell-adhesion molecules such as neurofascin-155, contactin-1, contactin-associated protein 1, and various neurofascin isoforms. This evidence concerns the gene NFASC and chronic inflammatory demyelinating polyradiculoneuropathy.